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Sema3A-induced growth-cone collapse is mediated by Rac1
amino acids 17–32
Imre Västrik*†‡, Britta J. Eickholt*‡, Frank S. Walsh§, Anne Ridley¶
and Patrick Doherty*
Background: Neurons project their axons along specific pathways in order to
establish appropriate connections with their target cells. The rate and direction
of axonal growth is determined by interactions between the highly motile growth
cone and environmental cues that can act in either an attractive or a repulsive
manner. Locomotion is ultimately dependent upon the reorganisation of the
actin cytoskeleton and an established role for the Rho family of small GTPases
in regulating this process in non-neuronal cells identifies them as candidate
signalling molecules in growth cones. An inactive form of Rac1 has recently
been shown to inhibit the ‘growth-cone collapse’ response induced by chick
Sema3A, a protein that has recently been established as an important guidance
cue. The molecular basis for this inhibition remains unclear. 
Results: We have made a series of overlapping peptides from the amino-terminal
region of Rac1 and rendered them cell permeable by synthesis in tandem with an
established internalisation vector. We report here that a peptide encompassing
Rac1 amino acids 17–32 binds directly to the established Rac1-interacting
molecules PAK, WASP, 3BP-1 and p85βPI3K, but not to p67Phox. Furthermore,
the peptide can compete with activated Rac1 for target binding, and inhibits
Sema3A-induced growth-cone collapse. We also synthesised cell-permeable
peptides that correspond to the Cdc42/Rac1-binding (CRIB) motifs present in
PAK and N-WASP. Our results show that a CRIB-containing peptide from PAK,
but not that from N-WASP, inhibits growth-cone collapse and that the inhibitory
activity correlates with binding to Rac1 and not to Cdc42.
Conclusions: Our results suggest that Sema3A-induced growth-cone collapse
is mediated by Rac1 amino acids 17–32, and demonstrate the feasibility of
designing new cell-permeable inhibitors of small GTPases.
Background
Neuronal growth cones navigate along specific pathways
to establish the appropriate connections between neurons
and their target cells. The rate and direction of growth is
determined by interactions between the growth cone and
environmental cues that can act either in a positive (attrac-
tive) or negative (repulsive/inhibitory) manner (reviewed
in [1]). Locomotion is ultimately dependent upon the
reorganisation of the cytoskeleton, especially its cortical
actin meshwork, in lamellipodia and filopodia [2].
Prospective intracellular mediators of guidance signals are
members of the Rho family of small GTPases [2,3]. There
are at least 14 distinct Rho GTPases in mammalian cells;
the best characterised are Cdc42, Rac1 and RhoA. During
the past decade their effects on the organisation of the
actin cytoskeleton in mammalian fibroblasts have been
established; Cdc42 triggers the formation of filopodia,
Rac1 regulates the formation of lamellipodia and RhoA
triggers assembly of focal contacts and stress fibres. More
recently, the involvement of Rho GTPases in the regula-
tion of the actin cytoskeleton in response to external
stimuli has also been demonstrated in macrophages and
neurons. Additional roles, including the regulation of gene
expression and cell proliferation, have also recently been
revealed (reviewed in [4–6]).
The activity of Rho GTPases is regulated by the antago-
nistic actions of guanine-nucleotide exchange factors
(GEFs), which load G proteins with GTP and thus acti-
vate them, and GTPase-activating proteins (GAPs), which
activate the intrinsic GTPase activity of G proteins and
thus return them to the inactive state. In addition, the
GTPases interact with so-called effector proteins, which
are the downstream targets that mediate the effects of the
GTPases (reviewed in [4–6]). Some of the Cdc42- and/or
Rac1-binding proteins (for example the kinases PAK,
ACK and MLK2/3 and the Wiskott-Aldrich syndrome
protein WASP) contain a consensus sequence motif
(CRIB, for Cdc42/Rac1 interactive binding [7]), which is
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believed to mediate the interaction. Others (for example
Citron, S6 kinase, POR-1, p35, and phosphatidylinositol
3-kinase (p85PI3K)) evidently lack the CRIB sequence and
bind through a different motif [8]. Different effectors or
sets of effectors are thought to mediate the diverse effects
of Rho GTPases.
Point mutations in Rho proteins can abolish interactions
with their specific downstream effectors and this has been
used to test the requirement for individual effectors in bio-
logical responses [9], an approach first described for the
analysis of Ras targets [10]. The mutations are generally
introduced in the context of constitutively active forms of
the GTPase (for example the V12 mutation), which, by
design, are uncoupled from upstream stimuli. This
approach is therefore limited, as it does not permit the
study of GTPase–effector interactions in response to a spe-
cific external stimulus. Such studies would greatly benefit
from the development of cell-permeable agents that can
compete with downstream effector molecules for binding
to GTPases. Identification of amino-acid sequences
involved in binding of the GTPase to the effector would
enable the development of competitive peptide mimics,
provided that these peptides could be introduced into cells.
One way of achieving this could be fusion of peptides to a
16 amino-acid region of the Antennepedia homeodomain
protein (also known as Penetratin) which has been shown
to allow delivery of peptides into living cells [11].
We have used the experimental paradigm of the growth-
cone collapse response induced by the repulsive axon
guidance molecule Sema3A to investigate the role of
GTPases in the regulation of the actin cytoskeleton in
neurons [12]. Sema3A (also known as collapsin-1) is a
member of the Class III semaphorin family of secreted
molecules that act as repulsive factors for particular axonal
populations. The binding of Sema3A to the transmem-
brane receptor neuropilin-1 is required for the collapse
response [13,14]; however, neuropilins lack any evident
signalling motifs and thus the nature of the signalling is
obscure. Nevertheless, two recent reports have demon-
strated that Sema3A-induced growth-cone collapse is
blocked by expression of an inactive form of Rac1
(N17Rac1), which is presumed to act as a specific domi-
nant-negative mutant [15,16]. The involvement of Cdc42
in the collapse response is unclear, as the two reports offer
contradictory results on this point. To clarify the role of
different Rho GTPases and effector molecules in growth-
cone collapse we have developed cell-permeable peptide
inhibitors of GTPase–effector interactions. We have
approached the problem from both the GTPase and the
effector side by designing cell-permeable peptides that
correspond either to overlapping fragments of the Rac1
effector-binding domain, or to CRIB motifs from the Rac1
and/or Cdc42 effector molecules PAK and N-WASP.
These peptides have been tested for their ability to bind
to GTPases and/or GTPase effectors, and for their ability
to inhibit the growth-cone collapse response.
Results
Peptide 17–32 from Rac1 interacts with Rac1 targets and
inhibits growth-cone collapse 
On the basis of their similarity to the more distant relative
Ras, Rho GTPases are likely to bind to their targets via the
amino-terminal third of the molecule. This includes a
region that undergoes conformational change on
GDP/GTP switching and is known as the effector loop.
Specific point mutations in this region affect the target
specificity of the GTPase. It is, however, unclear whether
these amino acids are directly involved in the GTPase–target
contacts or whether they change the GTPase conformation.
Rac1, Cdc42, RhoA and Ras have a high degree of
sequence identity. There are, however, also distinct differ-
ences in sequence, which are likely to be responsible for
the fact that the molecules interact with different effectors,
and are obvious candidates for the development of specific
inhibitors (Figure 1). We decided to target the interactions
of Rac1 as it is the GTPase most clearly implicated in
Sema3A signalling. We synthesised a set of four overlap-
ping peptides covering amino acids 17–56 of Rac1
(Figure 1). All peptides were synthesised in tandem with
the Penetratin internalisation sequence, and had an amino-
terminal biotin for detection and immobilisation. We tested
the peptides for their ability to bind to known Rac1-inter-
acting molecules — PAK, WASP, 3BP-1, p85βPI3K and
p67Phox. Using bacterially produced purified GST fusion
proteins of the GTPase-binding domains (GBD) of PAK,
WASP, p85βPI3K and p67Phox we found that, whereas
GST–p67Phox1–238 failed to interact with any of the pep-
tides, the others bound specifically to the peptide encom-
passing amino acids 17–32 of Rac1 (Figure 2a). Furthermore,
we were also able to show that the same peptide interacted
with endogenous 3BP-1 in Swiss 3T3 cell lysates
(Figure 2a). In addition, we tested the four peptides for
their ability to compete with Rac1 for binding to PAK.
Lysates from COS cells expressing activated Rac1 (V12
mutants) were incubated with immobilised GST–PAK65–137
in the absence or presence of Rac1 peptides. In agreement
with the above results, only the 17–32 peptide inhibited
binding of Rac1 to GST–PAK65–137 (Figure 2b). Thus we
can conclude that a short linear peptide from Rac1 specifi-
cally binds target proteins, and that it effectively competes
with intact activated Rac1 for binding to a target. PAK can
also interact with active Cdc42, and it is therefore not sur-
prising that the Rac1-derived PAK-binding peptide can
compete with Cdc42 for PAK binding, albeit to a lesser
degree (Figure 2b).
The effect of the Rac1 peptides on growth-cone collapse
was studied using explants of embryonic day 7 (E7) chick
dorsal root ganglia (DRG). Treatment of DRG explants
with an Fc chimeric version of Sema3A (see [17] for details)
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caused an increase in the number of collapsed growth cones
from the basal level of 15% to around 80% (Figure 3). Pep-
tides added at 40 µg/ml to DRG explants had no significant
effect on the basal level of collapsed growth cones
(Figure 3), nor did they cause any evident change in
growth-cone morphology (data not shown). However, the
Rac1 17–32 peptide dramatically inhibited the growth-cone
collapse induced by treatment with Sema3A (Figure 3). In
contrast, the other three Rac1-derived peptides had no
effect on the collapse response. Thus there is a clear corre-
lation between the ability of Rac1 peptides to bind to
targets and compete for a Rac1–effector interaction and
their ability to inhibit the growth-cone collapse response.
We made an equivalent set of peptides from Cdc42 and
tested them in parallel in the biochemical assay. The
Cdc42 17–32 peptide was indistinguishable from Rac1
17–32 in that it bound to the same tested targets and com-
peted with either Rac1 or Cdc42 for binding to
GST–PAK65–137 (Figure 2). This is perhaps not surprising
considering the high degree of sequence identity between
these two peptides (14 out of 16 residues, Figure 1a).
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Figure 1
The Rac1 peptides used in the present study.
(a) Alignment of amino-termini of c-Ha-Ras,
RhoA and Cdc42 with Rac1. Identical amino-
acid residues are boxed. The sequence of
Rac1-derived peptides is shown below the
alignment. All the peptides contain amino-
terminal biotin, ε-amino hexanoic acid (εAhx)
and the Penetratin internalisation sequence
(underlined). Biotin allows capture and
detection of the peptides and εAhx functions
as a spacer. Colour coding identifies the
location on the peptides on the three-
dimensional structure of Rac1 (b). The
structure is based on coordinates published
by Hirshberg et al. [30].
c-Ha-Ras M T E Y KL V V V G A G G V G K S A L T I Q L IQ N H FV D E Y P T IE D S Y R K Q V V I D G E TC L LD IL D TA G ...
RhoA M A A I R K KL V I V G D G A C G K TC L L I V FS K D Q FP E V Y P TV FE N Y V A D I E V D G K Q V E LA LW D TA G ...
Cdc42 M Q T IKC V V V G D G A V G K TC L L I S Y T TN K FP S E Y P TV FD N Y A V TV M I G G E P Y T LG LF D TA G ...
Rac1 M Q A IKC V V V G D G A V G K TC L L I S Y T TN A FP G E Y P TV FD N Y S A N V M V D G K P V N LG LW D TA G ...
10 20 30 40 50 60
Rac1 17–32 T C L L IS Y T T N A F P G E Y
Rac1 25–40 Biotin-εAhx-RQIKIWFQNRRMKWKK T N A F P G E Y IP T V F D N Y
Rac1 33–48 Biotin-εAhx-RQIKIWFQNRRMKWKK IP T V F D N Y S A N V M V D G
Rac1 41–56
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Figure 2
Interaction of Rac1-derived peptides with Rac1-binding proteins.
(a) Affinity precipitation of GST–p67Phox1–238, GST–PAK65–137,
GST–WASP201–321, the Bcr homology domain (HD) of p85βPI3K and
3BP-1 with Rac1 peptides. Peptide-saturated streptavidin–agarose
was incubated with the indicated protein or with Swiss 3T3 lysate (for
3BP-1) followed by washes. Agarose-bound proteins were separated
on SDS–PAGE and visualised by silver staining or western blotting
with anti-3BP-1 antiserum. The first lane indicates the amount of
recombinant protein used in the binding assay (except in the case of
3BP-1). Cdc42 17–32 peptide was used for comparison. (b) Ability of
Rac1 and Cdc42 17–32 peptides to compete for the binding of Rac1
and Cdc42 to GST–PAK GTPase-binding domains (GBD). Lysates
from COS cells expressing 9E10 epitope-tagged V12Rac1 or
V12Cdc42 were incubated with immobilised GST–PAK GBD in the
absence or presence of indicated peptides followed by washes,
SDS–PAGE and western blotting with 9E10 antibody.
N
o 
pe
pt
id
e
Rac1
17
–3
2
25
–4
0
33
–4
8
41
–5
6
R
ac
1
Cdc42
   Current Biology
L
ys
at
e
17
–3
2
C
dc
42
(a)
In
pu
t/
ly
sa
te
17
–3
2
25
–4
0
33
–4
8
41
–5
6
N
o 
pe
pt
id
e R
ac
1
3BP-1
p85βPI3KBcr HD
GST–WASP201–321
GST–PAK65–137
GST–p67Phox 1–238
C
dc
42
17
–3
2
(b) GST–PAK65–137
What is perhaps surprising, however, is the observation
that this peptide had little or no effect on the growth-cone
collapse response (Figure 3). 
A CRIB-motif peptide from PAK interacts with GTPases and
blocks the collapse response
The Rac1 17–32 peptide can bind to Rac1-interacting pro-
teins and thus outcompetes the binding of the target
protein to activated Rac1. However, given that some effec-
tors use the same binding domain (for example CRIB) to
interact with a subset of GTPases, one would expect that
the Rac1-derived peptide would also compete for effector
binding to other GTPases. To complement the above
approach, we designed effector-based peptides that would
be expected to outcompete GTPase–target interactions by
binding back to the GTPase itself. A number of structures
(for example Dbl and Bcr/GAP homology domains and
CRIB) bind to GTPases [7,18], with the CRIB motif being
of particular interest in that it is a relatively short linear
sequence. On the basis of published reports, CRIB motifs
from different molecules may have distinct specificities for
GTPases. For example, PAK has been reported to bind to
both Rac1 and Cdc42 [7], whereas N-WASP has been
reported to bind only to Cdc42 [19]. We therefore synthe-
sised biotinylated peptides of 16 amino acids, based on the
CRIB motifs from PAK or N-WASP in tandem with the
Penetratin internalisation vector (Figure 4).
The PAK and N-WASP CRIB peptides were tested for
their ability to bind directly to activated RhoA, Rac1 and
Cdc42 (Figure 5a). In agreement with their known speci-
ficities (see above), both peptides interacted with activated
Cdc42, the PAK peptide also interacted with Rac1, and
none of the peptides interacted with RhoA. As an additional
control, the peptides showed no direct interaction when the
PAK and N-WASP sequences were reversed (BIRC pep-
tides, see Figure 5a). We next determined whether the
‘target’-derived peptides could compete for activated
GTPase–target interactions. Interaction of PAK with Cdc42
in transfected COS cell lysates was clearly inhibited by both
PAK and N-WASP CRIB peptides (Figure 5b). PAK
binding to Rac1 was also inhibited by both peptides
(Figure 5b), and this was perhaps unexpected given that we
could not detect a direct interaction between the N-WASP
CRIB peptide and Rac1. However, the competition assay
would be expected to be more sensitive than a direct pre-
cipitation assay. As a control, the BIRC peptides had little
or no effect on the GTPase–PAK interaction.
The peptides were further tested in the growth-cone col-
lapse assay. On their own, the PAK and N-WASP CRIB
peptides had no effect on the basal numbers of collapsed
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Figure 3
The Rac1 17–32 peptide inhibits Sema3A-induced growth-cone
collapse. Dorsal root ganglia (DRG) explants from E7 chick embryos
were cultured in the presence of nerve growth factor (NGF) for
20–24 h. Peptides were added to a final concentration of 40 µg/ml for
1 h. Sema3A–Fc chimeric protein was added to a concentration of
1 µg/ml for 30 min. The data are from at least three independent
experiments with duplicate samples.
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Figure 4
Sequence of PAK and N-WASP CRIB peptides. Peptides with the
CRIB sequences reversed (BIRC) were made as a control.
Penetratin
Current Biology  
CRIB
PAK CRIB Biotin- εAhx-RQIKIWFQNRRMKWKK E I S L P S D F E H T I H V G F
N-WASP CRIB Biotin- εAhx-RQIKIWFQNRRMKWKK D I G T P S N F Q H I G H V G W
PAK BIRC Biotin- εAhx-RQIKIWFQNRRMKWKK F G V H I T H E F D S P L S I E
N-WASP BIRC Biotin- εAhx-RQIKIWFQNRRMKWKK W G V H G I H Q F N S P T G I D
Figure 5
Differential binding of PAK and N-WASP CRIB peptides to activated
Rac1. (a) Peptide-saturated streptavidin–agarose was incubated with
lysates from COS cells expressing 9E10 epitope-tagged V14RhoA,
V12Rac1 or V12Cdc42. Peptide-bound proteins were subjected to
SDS–PAGE followed by western blotting with 9E10 antibody. (b) Both
PAK and N-WASP CRIB peptides inhibit binding of Rac1 and Cdc42
to GST–PAK GBD. Lysates from COS cells expressing 9E10 epitope-
tagged V12Rac1 or V12Cdc42 were incubated with immobilised
GST–PAK in the absence or presence of indicated peptides followed
by washes, SDS–PAGE and western blotting with 9E10 antibody.
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growth cones in the cultures. Interestingly, whereas the
PAK CRIB peptide substantially inhibited the growth-
cone collapse response, the N-WASP CRIB peptide had
no effect (Figure 6). We used the biotin tag to localise
both CRIB peptides in growth cones, and the results
suggest that both are internalised to a similar extent
(Figure 6b). This indicates that their differential effect on
growth-cone collapse is unlikely to be caused by differ-
ences in internalisation efficiency. Surprisingly, both of
the BIRC peptides induced the collapse of a small per-
centage of the growth cones under control conditions, with
the PAK BIRC peptide also showing a marginal inhibitory
effect towards Sema3A. These less than substantial effects
are likely to be non-specific.
Discussion
The traditional method of establishing an involvement of
Rac1 and Cdc42 in a particular physiological or cellular
process is to overexpress inactive mutants of the proteins.
This approach has been used successfully in numerous
model and assay systems. These mutants are believed to
function by sequestering GEFs and thus outcompeting
the activation of endogenous GTPases in a dominant-neg-
ative manner. However, this approach does not allow the
dissection of events downstream of GTPase activation,
and is compromised by the fact that subsets of GTPases
can use the same GEFs. The involvement of distinct sig-
nalling molecules has been studied using constitutively
active GTPases with specific point mutations in the
region that affects their interactions with downstream
molecules. However, as this approach uses GTPases that
have been uncoupled from upstream regulators, it is of
limited applicability.
Another possible caveat to this approach is the delivery
technique itself. Especially with small delicate structures
like growth cones, an invasive technique such as micro-
injection is not ideal. In addition, it is laborious and techni-
cally hard to microinject a large number of cells. Thus
investigation of GTPase–effector interactions would greatly
benefit from the development of novel inhibitors, that could
be delivered into the cells in a passive manner. Mimetic
peptides, based on linear interaction sites, are useful phar-
macological tools for the study of protein–protein interac-
tions because they can act as competitive inhibitors. This
approach has been used, for example, in disrupting the
interactions of proteins containing Src homology 2 (SH2) or
phosphotyrosine-binding (PTB) domains with tyrosine-
phosphorylated proteins [20–22], and of SH3-containing
molecules with proline-rich proteins [23]. Similarly, a
peptide from the Ras effector area has been shown to
inhibit interaction of Raf with Ras [24]. However, whereas
phosphotyrosine-containing peptides have been shown to
interact with SH2 and PTB domains in a very stable
manner, to our knowledge there has been no demonstration
of direct binding between a small fragment of a GTPase and
an interacting protein. As GTPases are supposed to bind
their effector molecules only in their active GTP-loaded
state, and as there is no modification of the protein primary
structure, one might expect that the GTPase-derived pep-
tides would not bind to the target molecules stably, if at all.
However, we have demonstrated here by affinity precipita-
tion, the interaction of 17–32 peptides from Rac1 and Cdc42
with various target molecules, and this suggests that these
interactions are relatively stable. The interactions were spe-
cific in that three other Rac1 peptides failed to interact with
any of these molecules, and the 17–32 peptides did not bind
to another Rac1 target, p67Phox. In the case of PAK at least,
the 17–32 peptide is clearly interacting with the Rac1-
binding site on PAK (presumably the CRIB site), as it could
also completely inhibit the binding of activated Rac1 to
PAK. Interestingly, a mutation of Tyr40 in activated Rac1
(and Cdc42) disrupts binding to PAK [9], suggesting addi-
tional contacts between Rac1 and PAK. Indeed, recently
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Figure 6
The PAK CRIB peptide inhibits Sema3A-induced growth-cone
collapse. (a) DRG explants from E7 chick embryos were cultured in
the presence of NGF for 20–24 h. Peptides were added to a final
concentration of 40 µg/ml for 1 h. Sema3A–Fc was added to a
concentration of 1 µg/ml for 30 min. The data are from at least five
independent experiments. (b) Staining for internalised PAK and
N-WASP CRIB peptides in the growth cones. Overnight cultures of
DRG explants were treated with 40 µg/ml of indicated peptides for 1 h,
washed and fixed. Peptides were visualised with streptavidin–TRITC.
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resolved solution structures of Cdc42 with the GTPase-
binding domains of WASP [25] and ACK [26] support the
idea of a relatively large interaction face that does indeed
include residues 17–32 and Tyr40. However, two addi-
tional Rac1 peptides that contain Tyr40 failed to bind
PAK and were unable to inhibit the Rac1–PAK interac-
tion. This suggests that although the region around Tyr40
might be required for binding, it is not sufficient for
binding. In contrast, the 17–32 region is clearly both
required and sufficient for binding.
An almost identical sequence to the Rac1 17–32 motif is
present in Cdc42, and both these GTPases interact with
the CRIB motif of PAK (and of several other targets). It
is perhaps not surprising that the Rac1 peptide (which
should bind to the CRIB motif of PAK) can also inhibit
the binding of Cdc42 to PAK, nor is it surprising that the
Cdc42 17–32 peptide can outcompete the binding of
Rac1 to PAK. However, what is interesting is that both
the Rac1 and Cdc42 17–32 peptides are much less effec-
tive at inhibiting the Cdc42–PAK interaction relative to
the Rac1–PAK interaction. One possibility is that Cdc42
interactions with its targets are more difficult to compete
with because Cdc42 uses a larger face than Rac1 to bind
the same target molecule. Indeed, the three-dimensional
structures of Cdc42 with WASP [25] and ACK [26] both
point to a relatively large interaction face. Furthermore,
in a series of pull-down experiments we have observed
that additional Cdc42 effector loop peptides (for example
the 33–48 peptide) can pull down the same targets as the
17–32 peptide (I.V., unpublished observation), whereas
in the case of Rac1, we only found binding activity with
the 17–32 peptide.
Somewhat surprisingly we found that four out of the five
proteins tested interacted with the 17–32 region of Rac1
and Cdc42. This demonstrates that both CRIB and
Bcr/GAP homology domains interact with the same
region of Rac1. As the 17–32 peptide inhibited the
growth-cone collapse response, any of these interacting
molecules might be important in Sema3A signalling.
However, as dominant-negative Rac1 has been shown to
block collapse, thus indicating a requirement for active
Rac1 in the process [15,16], and as 3BP-1 inhibits Rac1
[27], inhibition of 3BP-1 (or GAPs in general) by a
peptide is not likely to explain its mechanism of action.
Furthermore, the ability of Cdc42 17–32 peptide to bind
to the very same targets while not inhibiting the collapse
response strongly suggests that none of the tested targets
is important in Sema3A-induced growth-cone collapse.
An obvious possibility is that an alternative Rac1-specific
effector molecule is required for the collapse response,
and could interact exclusively with the Rac1 peptide.
However, we cannot rule out the possibility that the dif-
ferential effect of Rac1 and Cdc42 17–32 peptides in the
collapse assay is due to differences in the binding kinetics
to a common target which are too subtle to be picked up
in our biochemical assays. 
If Rac1 function is indeed required for the collapse
response, a peptide from a target molecule which is able to
bind back to the effector loop of Rac1 should act as a com-
petitive inhibitor. The ideal peptide would clearly be from
a target that interacts exclusively with Rac1. However, as
we have not yet identified such a peptide we decided to
test a peptide from a presumptive Cdc42-only target
(N-WASP) and a peptide from a Cdc42 and Rac1 target
(PAK). In agreement with the published data [7,19], we
readily demonstrated that a PAK CRIB peptide can bind
directly to both Cdc42 and Rac1, whereas an N-WASP
CRIB peptide bound only to Cdc42. In agreement with
the above hypothesis we did indeed find that only the
peptide that bound effectively to Rac1 inhibited the
growth-cone collapse response. Unfortunately, the PAK
peptide would be expected to compete for a Rac1 interac-
tion with any target that interacts with the same region of
the effector loop, and so, although this observation impli-
cates Rac1 function in the collapse response, it does not
cast any light on the nature of the downstream target. 
In summary, our results show that a cell-permeable
peptide mimic of the amino-acid 17–32 region of the Rac1
effector loop can interact with a range of Rac1 targets and
inhibits the growth-cone collapse response. Furthermore,
a cell-permeable target-derived peptide that binds back to
this region of the Rac1 effector loop also inhibited the col-
lapse response. Both observations demonstrate the feasi-
bility of designing new cell-permeable inhibitors of small
GTPases and suggest that Sema3A-induced growth-cone
collapse is mediated by an effector molecule that binds to
Rac1 amino acids 17–32.
Materials and methods
Peptides
Peptides were synthesised on a 431A Applied Biosystems peptide
synthesiser using p-hydroxymethylphenoxymethyl polystyrene resin and
standard Fmoc chemistry. All peptides were made as linear sequences
with amino-terminal biotin and ε-amino hexanoic acid (εAhx). Biotin
allows capture and detection of the peptides and εAhx functions as
spacer. After synthesis and deprotection, peptides were purified on a
C18 column using reverse phase HPLC and lyophilised.
Constructs
The GST–p67Phox1–238 and GST–WASP201–321 constructs were
based on pGEX2T and were gifts from Sohail Ahmed (Institute of Neu-
rology, London, UK) and Pontus Aspenström (Ludwig Institute,
Uppsala, Sweden), respectively. The GST–PAK65–137 construct (a gift
from Shubha Bagrodia, Cornell University, USA) is based on pGEX-KG
and contains mouse PAK3 amino acids 65–137 [28]. Eluted fusion
proteins were stored in aliquots in liquid nitrogen. For GST–PAK
GTPase-binding domain (GBD) affinity precipitation, the protein was
left bound to the GSH–Sepharose beads, which were stored aliquoted
in liquid nitrogen. All Rho family proteins were constitutively active
mutants (that is, V14RhoA, V12Rac1, V12Cdc42) and were expressed
as amino-terminally 9E10 epitope-tagged derivatives using pEFplink
([29], gift from Richard Treisman, ICRF, London, UK).
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Affinity precipitation
Peptide affinity precipitation of GST–p67Phox1–238, GST–PAK65–137 and
GST–WASP201–321 were performed with 20 µl of peptide-saturated
streptavidin agarose (Sigma), which was incubated with 5 µg of each
protein in 100 µl buffer Y (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM
EDTA, 1% NP-40) with 1 mM dithiothreitol (DTT) for 1 h at 4ºC. Precip-
itates were washed four times with 1 ml buffer Y and subjected to
SDS–PAGE analysis on 10% gels. The proteins were visualised by
silver staining. Affinity precipitation of 3BP-1 was performed using a
10 cm plate of quiescent Swiss 3T3 cells per sample. Cells were lysed
in 1 ml buffer Y with with 1 mM DTT and Complete protease inhibitors
(Boehringer Mannheim). Lysates were cleared by brief centrifugation
and incubated with 20 µl peptide-saturated streptavidin agarose for 1 h
at 4ºC. Precipitates were washed four times with 1 ml buffer Y and sub-
jected to SDS–PAGE analysis on 10% gels followed by transfer to
nitrocellulose filters. 3BP-1 was detected using affinity-purified poly-
clonal antibody [27] and visualised using enhanced chemiluminescence
(ECL). For peptide affinity precipitations of Rho GTPases, COS cells
were electroporated with 5 µg of appropriate expression constructs.
On the following day the cells were washed twice with cold PBS on ice
and lysed in Mg buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10 mM
MgCl2, 1% NP-40) with 1 mM DTT and Complete protease inhibitors.
Lysates were cleared by brief centrifugation and incubated with 20 µl
peptide-saturated streptavidin agarose for 1 h at 4ºC. Precipitates were
washed four times with 1 ml Mg buffer and subjected to SDS–PAGE
analysis on 12% gels followed by transfer to nitrocellulose filters. 9E10
epitope-tagged GTPases were detected with 9E10 antibody (Santa
Cruz Biotechnology) and visualised using ECL.
For peptide competition experiments, COS cells were electroporated
with 5 µg of appropriate expression constructs. On the following day
the cells were washed twice with cold PBS on ice and lysed in Mg
buffer (50 mM Tris pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1% NP-40)
with 1 mM DTT and Complete protease inhibitors (Boehringer
Mannheim). Lysates were cleared by brief centrifugation. CRIB and
BIRC peptides were added to the lysates at 100 µg/ml and the mixture
was incubated for 30 min at 4ºC. Sepharose-bound GST–PAK GBD
was added and incubation in the same conditions was continued for
5 min. Rac1 peptides were added to the sepharose-bound GST–PAK
GBD in the lysis buffer at 200 µg/ml. The mixture was incubated for
20 min at 4ºC. Cell lysates were added in equal volume and incubation
continued for 5 min. Precipitates were washed four times with 1 ml Mg
buffer and subjected to SDS–PAGE analysis on 12% gels followed by
transfer to nitrocellulose filters. 9E10 epitope-tagged GTPases were
detected with 9E10 antibody and visualised using ECL.
Growth-cone collapse assay
The collapse assay was performed as described by Eickholt et al. [17].
Briefly, dorsal root ganglia from embryonic day 7 (E7) chick embryos
were removed in L-15 medium, cut in half and plated onto chamber
slides (Gibco) which had been coated with laminin (20 µg/ml). The
explants were kept in DMEM supplemented with 10% FCS,
penicillin–streptomycin mix and 20 ng/ml NGF for 20–24 h. Peptides
were first diluted to 10 × concentration in water and added to the
medium for 1 h. Sema3A–Fc was added to the concentration of
1 µg/ml for 30 min followed by fixation in 4% paraformaldehyde con-
taining 10% sucrose. The actin cytoskeleton was visualised with phal-
loidin–TRITC and the fraction of neurite tips without lamellipodia and
filopodia was determined.
Visualisation of internalised peptides
Dorsal root ganglion explants were prepared as described above. After
peptide treatment, samples were washed twice with PBS and fixed in
cold acetone:methanol (1:1) for 5 min. Peptides were visualised by
extravidin–TRITC (Sigma).
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